NCT04153123

Brief Summary

Evaluate ophthalmic artery flow by echo-Doppler before and after peribulbar block with lidocaine in presence or absence of epinephrine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2014

Completed
5.4 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2019

Completed
Last Updated

November 6, 2019

Status Verified

November 1, 2019

Enrollment Period

6 months

First QC Date

November 3, 2019

Last Update Submit

November 5, 2019

Conditions

Keywords

ocular flowcataract surgeryperibulbar blockocular Doppler

Outcome Measures

Primary Outcomes (1)

  • Artery resistance index of ophthalmic artery

    The resistance index (RI) of OA was evaluated using echo-Doppler before and 10 minutes after the peribulbar block.

    Change on resistance index 10 minutes after peribulbar anesthesia

Study Arms (2)

Lidocaine with epinephrine

EXPERIMENTAL

Peribulbar anesthesia with lidocaine and epinephrine

Drug: Epinephrine

Lidocaine without epinephrine

NO INTERVENTION

Peribulbar anesthesia with lidocaine

Interventions

Lidocaine with epinephrine

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) I, II or III physical status classification
  • Cataract surgery

You may not qualify if:

  • glaucoma
  • diabetic retinopathy
  • previous eye surgery in the same eye
  • ocular trauma
  • allergic to any protocol medication
  • uncooperative patients or cognitive difficulties
  • axial eye diameter of less than 21.0 mm or greater than 25.5 mm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Cirurgia.

Belo Horizonte, Minas Gerais, 30130100, Brazil

Location

MeSH Terms

Interventions

Epinephrine

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The preparation of the syringes was performed by one of the researchers not involved in the execution of the blockades. The same anesthesiologist performed all the blocks, while the same ophthalmologist did the ocular monitoring measures.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Group 1: Peribulbar anesthesia with 2% lidocaine with epinephrine 1/200,000. Group 2: Peribulbar anesthesia with 2% lidocaine without epinephrine.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 3, 2019

First Posted

November 6, 2019

Study Start

December 1, 2013

Primary Completion

May 31, 2014

Study Completion

May 31, 2014

Last Updated

November 6, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

The data will be present at an official journal

Locations